140 related articles for article (PubMed ID: 26648519)
1. Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways.
Grossebrummel H; Peter T; Mandelkow R; Weiss M; Muzzio D; Zimmermann U; Walther R; Jensen F; Knabbe C; Zygmunt M; Burchardt M; Stope MB
Int J Oncol; 2016 Feb; 48(2):793-800. PubMed ID: 26648519
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate.
Kim W; Jones JO; Diamond M; Haqq C; Molina A; Small EJ; Ryan CJ
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):292-9. PubMed ID: 25047002
[TBL] [Abstract][Full Text] [Related]
4. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
5. Emodin induces apoptosis in human prostate cancer cell LNCaP.
Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
[TBL] [Abstract][Full Text] [Related]
6. Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation.
Kawanami T; Tanaka T; Hamaguchi Y; Nomiyama T; Nawata H; Yanase T
Endocrinology; 2018 Apr; 159(4):1774-1792. PubMed ID: 29444261
[TBL] [Abstract][Full Text] [Related]
7. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
[TBL] [Abstract][Full Text] [Related]
8. Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity.
Wang X; Huang Y; Christie A; Bowden M; Lee GS; Kantoff PW; Sweeney CJ
Clin Cancer Res; 2015 Dec; 21(24):5578-87. PubMed ID: 26289068
[TBL] [Abstract][Full Text] [Related]
9. Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.
Verma V; Sharma V; Singh V; Sharma S; Bishnoi AK; Chandra V; Maikhuri JP; Dwivedi A; Kumar A; Gupta G
Toxicol Appl Pharmacol; 2014 Oct; 280(2):323-34. PubMed ID: 25123791
[TBL] [Abstract][Full Text] [Related]
10. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
12. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
[TBL] [Abstract][Full Text] [Related]
13. Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status.
Nikhil K; Sharan S; Chakraborty A; Roy P
PLoS One; 2014; 9(4):e93335. PubMed ID: 24699278
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
15. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
16. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
18. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells.
Kadowaki Y; Chari NS; Teo AE; Hashi A; Spurgers KB; McDonnell TJ
Apoptosis; 2011 Jun; 16(6):627-35. PubMed ID: 21437722
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
[TBL] [Abstract][Full Text] [Related]
20. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
Yan J; Xie B; Capodice JL; Katz AE
Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
